The effect of a single neonatal treatment (hormonal imprinting) with the antihormones, tamoxifen and mifepristone on the sexual behavior of adult rats.
Hormonal imprinting takes place perinatally during the first encounter between the hormone and its developing receptor. The presence of an excess of related molecules in that time provokes faulty (pathological) imprinting. In the present experiments single-neonatal treatment with 100 microg of tamoxifen completely abolished the adult male and female rats' sexual activity. Similar treatment with 100 microg of mifepristone (RU486) significantly enhanced the males sexual activity and non-significantly increased that of the females. The results demonstrate the importance of pathological imprinting during the perinatal development of sexual behavior. There are clear differences between the molecules having steroid (mifepristone) or non-steroid (tamoxifen) character, mediated through a ligand-receptor complex, and its effect in activating particular genes.
Csaba
G
G
Department of Genetics, Cell and Immunobiology, Semmelweis University, H-1445 Budapest, P.O. Box 370, Hungary. csagyor@dgci.sote.hu
Karabélyos
C
C
D000818:Animals; D000831:Animals, Newborn; D003307:Copulation / Q000187:drug effects; D004542:Ejaculation / Q000187:drug effects; D004965:Estrogen Antagonists / Q000494:pharmacology*; D005260:Female; D006727:Hormone Antagonists / Q000494:pharmacology*; D007279:Injections, Subcutaneous; D008297:Male; D015735:Mifepristone / Q000008:administration & dosage / Q000494:pharmacology*; D010052:Ovariectomy; D011187:Posture; D011374:Progesterone / Q000008:administration & dosage / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D011980:Receptors, Progesterone / Q000378:metabolism; D020845:Selective Estrogen Receptor Modulators / Q000378:metabolism; D012726:Sexual Behavior, Animal / Q000187:drug effects* / Q000502:physiology; D013629:Tamoxifen / Q000008:administration & dosage / Q000494:pharmacology*
D004965:Estrogen Antagonists; D006727:Hormone Antagonists; D011980:Receptors, Progesterone; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D015735:Mifepristone; D011374:Progesterone